DexCom
DXCM
DXCM
363 hedge funds and large institutions have $12.7B invested in DexCom in 2018 Q3 according to their latest regulatory filings, with 92 funds opening new positions, 96 increasing their positions, 131 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
10% less call options, than puts
Call options by funds: $73.8M | Put options by funds: $81.6M
21.48% less ownership
Funds ownership: 423.38% → 401.9% (-21%)
27% less repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 131
Holders
363
Holding in Top 10
7
Calls
$73.8M
Puts
$81.6M
Top Buyers
| 1 | +$476M | |
| 2 | +$117M | |
| 3 | +$85.7M | |
| 4 |
JP Morgan Chase
New York
|
+$74.3M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
+$66.3M |
Top Sellers
| 1 | -$603M | |
| 2 | -$391M | |
| 3 | -$155M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$110M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$104M |